Product Information

METFORMIN HCL 625 MG TABLET is a generic product labeled by Lifsa Drugs LLC, priced at $12.5266 per EA under NDC 72336006430. Its NADAC has been published 57 times since Jul 23, 2025.

FDA first approved this application on Jan 24, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metformin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for METFORMIN HCL 625 MG TABLET has been published 57 times since Jul 23, 2025, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.